Skip to content

Apotheek D. VERHAERT

Active
Private limited companyfounded 1961active for 65 yearsKapelsesteenweg 81, 2180 Antwerpen, BelgiumKBO/BCE: BE 0403.843.563
Summary

Apotheek D. VERHAERT has been active since 1961 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €197,228 and a net result of €1,256. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 39% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€740,491total assets 2025
Equity
€197,228
Profit
€1,256
Turnover not published (abbreviated or micro format)
Financial health
85 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
DORINE VERHAERT · 100%
2025 accounts 4 days early3 deeds in the Belgian Official Gazette
Why 85raises riskLiquidity: current ratio 1.46, cash €5,982Sector: Retail trade (NACE 47)lowers riskSize: total assets €740,491Founded in 1961Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 31% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 52-2
equity 26.6% of total assets
Liquidity 15-5
short-term debt 67.7% · cash 0.8%
Profitability 34-41
return on assets 0.2%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,231 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.6%▲ +0.3 percentage points vs 12-2024highest value 02-2025: 0.2%▼ -0.4 percentage points vs 01-2025lowest value 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025lowest value 05-2025: 0.2%● unchanged vs 04-2025lowest value 06-2025: 0.2%● unchanged vs 05-2025lowest value 07-2025: 0.2%● unchanged vs 06-2025lowest value 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.3%▲ +0.1 percentage points vs 11-2025 01-2026: 0.4%▲ +0.1 percentage points vs 12-2025 02-2026: 0.2%▼ -0.2 percentage points vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.3%▲ +0.1 percentage points vs 09-2026
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.46, compared with 1.6 in 2024, below the usual 1.5; short-term debt: 67.7% and cash: 0.8% of total assets), and 73.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 42% on solvency, 14% on liquidity, 27% on profitability and 41% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €740,491
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 1.46, cash €5,982
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1961
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-01-2026, 4 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
4 days early
2024
9 days early
2023
29 days early
2022
6 days early
2021
on the day
2020
6 days early
2019
39 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 25 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end24-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by DORINE VERHAERT 100% View
  • Positive: 6 profitable years in a rowprofit 2025: €1,256 6 years View
  • Active since 1961founded 01-01-1961 65 years View

By topic

Financials

Financial year
2025
Total assets
€740,491
Profit
€1,256
Solvency
26.6%
Total assets▲ 8.9%
Net result
20192025
Go to Financials

Timeline

Events
51
Since
1978
Next accounts
by 31-01-2027
  1. 30-06-2023Equity above €150,000
  2. 25-01-2023Annual accounts filed
  3. 30-06-2022Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
01-01-1961
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Apotheek D. VERHAERT

What is the company number of Apotheek D. VERHAERT?
0403.843.563. In Belgium the VAT number is the company number with BE in front: BE 0403.843.563.
Where is Apotheek D. VERHAERT based?
The registered office is at Kapelsesteenweg 81, 2180 Antwerpen.Company details
What does Apotheek D. VERHAERT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek D. VERHAERT?
Private limited company (BV).
When was Apotheek D. VERHAERT founded?
On 01-01-1961.
Is Apotheek D. VERHAERT still active?
Yes, Apotheek D. VERHAERT is an active enterprise in the KBO register.
What is the turnover of Apotheek D. VERHAERT?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Apotheek D. VERHAERT profitable?
In financial year 2025, Apotheek D. VERHAERT made a profit of €1,256.
Where can I find the annual accounts of Apotheek D. VERHAERT?
Apotheek D. VERHAERT filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek D. VERHAERT due?
By 31-01-2027, for financial year 2026.Timeline

Companies related to Apotheek D. VERHAERT

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.